ACCELERON PHARMA INC Insider Trading for December 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for December 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 29 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | S | 38.00 | 3,187 | 121,106 | 0 | 3.2 K to 0 (-100.00 %) |
Dec 29 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | S | 38.00 | 51,163 | 1,944,194 | 0 | 51.2 K to 0 (-100.00 %) |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 3.88 | 15,000 | 58,200 | 36,240 | |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 3.88 | 15,000 | 58,200 | 15,000 | 0 to 15 K |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | M | 1.80 | 5,825 | 10,485 | 7,300 | |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | M | 0.92 | 3,985 | 3,666 | 0 | |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Buy | M | 1.80 | 5,825 | 10,485 | 37,700 | 31.9 K to 37.7 K (+18.27 %) |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Buy | M | 0.92 | 3,985 | 3,666 | 31,875 | 27.9 K to 31.9 K (+14.29 %) |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Option Exercise | M | 0.48 | 4,000 | 1,920 | 32,000 | |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 35,500 | |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 40.19 | 1,000 | 40,190 | 20,500 | 21.5 K to 20.5 K (-4.65 %) |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 40.60 | 200 | 8,120 | 20,004 | 20.2 K to 20 K (-0.99 %) |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 40.13 | 3,800 | 152,494 | 20,204 | 24 K to 20.2 K (-15.83 %) |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Buy | M | 0.48 | 4,000 | 1,920 | 24,004 | 20 K to 24 K (+20.00 %) |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Buy | M | 3.88 | 2,000 | 7,760 | 20,004 | 18 K to 20 K (+11.11 %) |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 15,000 | 58,200 | 110,751 | |
Dec 19 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 15,000 | 58,200 | 25,000 | 10 K to 25 K (+150.00 %) |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 23,867 | 0 | 28,734 | 4.9 K to 28.7 K (+490.38 %) |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | J | 0.00 | 23,867 | 0 | 251 | 24.1 K to 251 (-98.96 %) |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 13,136 | 0 | 13,136 | 0 to 13.1 K |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | J | 0.00 | 13,136 | 0 | 24,118 | 37.3 K to 24.1 K (-35.26 %) |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 712 | 0 | 37,254 | 36.5 K to 37.3 K (+1.95 %) |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 36,542 | 0 | 36,542 | 0 to 36.5 K |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 3,187 | 0 | 3,187 | 0 to 3.2 K |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Buy | J | 0.00 | 51,163 | 0 | 51,163 | 0 to 51.2 K |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | J | 0.00 | 60,496 | 0 | 30,248 | 90.7 K to 30.2 K (-66.67 %) |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Sell | J | 0.00 | 500,421 | 0 | 500,420 | 1 M to 500.4 K (-50.00 %) |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 0.92 | 4,000 | 3,680 | 3,500 | |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 41.72 | 2,500 | 104,300 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 40.72 | 1,500 | 61,080 | 2,500 | 4 K to 2.5 K (-37.50 %) |
Dec 16 2014 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 0.92 | 4,000 | 3,680 | 4,000 | 0 to 4 K |
Dec 15 2014 | XLRN | ACCELERON PHARMA I ... | MCGUIRE TERRANCE | Director | Sell | J | 0.00 | 403,166 | 0 | 2,218,572 | 2.6 M to 2.2 M (-15.38 %) |
Dec 12 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Option Exercise | M | 5.08 | 4,000 | 20,320 | 29,496 | |
Dec 12 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 43.73 | 500 | 21,865 | 21,500 | 22 K to 21.5 K (-2.27 %) |
Dec 12 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 43.16 | 500 | 21,580 | 22,000 | 22.5 K to 22 K (-2.22 %) |
Dec 12 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 43.88 | 1,065 | 46,732 | 18,004 | 19.1 K to 18 K (-5.58 %) |
Dec 12 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 43.32 | 2,935 | 127,144 | 19,069 | 22 K to 19.1 K (-13.34 %) |
Dec 12 2014 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Buy | M | 5.08 | 4,000 | 20,320 | 22,004 | 18 K to 22 K (+22.22 %) |
Dec 12 2014 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Option Exercise | A | 41.48 | 20,000 | 829,600 | 20,000 | |
Dec 10 2014 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 40.11 | 8,778 | 352,086 | 1,310,650 | 1.3 M to 1.3 M (-0.67 %) |
Dec 10 2014 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 46.02 | 5,486 | 252,466 | 1,814,434 | 1.8 M to 1.8 M (-0.30 %) |
Dec 10 2014 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Sell | S | 45.33 | 83,143 | 3,768,872 | 1,819,920 | 1.9 M to 1.8 M (-4.37 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 10,000 | 38,800 | 125,751 | |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 47.64 | 100 | 4,764 | 10,000 | 10.1 K to 10 K (-0.99 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 46.76 | 200 | 9,352 | 10,100 | 10.3 K to 10.1 K (-1.94 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 45.79 | 300 | 13,737 | 10,300 | 10.6 K to 10.3 K (-2.83 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 44.84 | 1,600 | 71,744 | 10,600 | 12.2 K to 10.6 K (-13.11 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 44.21 | 1,100 | 48,631 | 12,200 | 13.3 K to 12.2 K (-8.27 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 42.86 | 1,300 | 55,718 | 13,300 | 14.6 K to 13.3 K (-8.90 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 41.18 | 200 | 8,236 | 14,600 | 14.8 K to 14.6 K (-1.35 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 39.52 | 200 | 7,904 | 14,800 | 15 K to 14.8 K (-1.33 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 47.23 | 196 | 9,257 | 15,000 | 15.2 K to 15 K (-1.29 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 46.39 | 300 | 13,917 | 15,196 | 15.5 K to 15.2 K (-1.94 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 45.17 | 1,000 | 45,170 | 15,496 | 16.5 K to 15.5 K (-6.06 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 44.34 | 1,759 | 77,994 | 16,496 | 18.3 K to 16.5 K (-9.64 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 42.96 | 1,344 | 57,738 | 18,255 | 19.6 K to 18.3 K (-6.86 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 41.14 | 100 | 4,114 | 19,599 | 19.7 K to 19.6 K (-0.51 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 40.34 | 201 | 8,108 | 19,699 | 19.9 K to 19.7 K (-1.01 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 38.52 | 100 | 3,852 | 19,900 | 20 K to 19.9 K (-0.50 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 10,000 | 38,800 | 20,000 | 10 K to 20 K (+100.00 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 47.45 | 451 | 21,400 | 76,500 | 77 K to 76.5 K (-0.59 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 46.54 | 1,200 | 55,848 | 76,951 | 78.2 K to 77 K (-1.54 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 45.10 | 4,300 | 193,930 | 78,151 | 82.5 K to 78.2 K (-5.22 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 44.35 | 7,036 | 312,047 | 82,451 | 89.5 K to 82.5 K (-7.86 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 42.90 | 5,413 | 232,218 | 89,487 | 94.9 K to 89.5 K (-5.70 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 41.58 | 400 | 16,632 | 94,900 | 95.3 K to 94.9 K (-0.42 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 40.55 | 800 | 32,440 | 95,300 | 96.1 K to 95.3 K (-0.83 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 38.43 | 400 | 15,372 | 96,100 | 96.5 K to 96.1 K (-0.41 %) |
Dec 09 2014 | XLRN | ACCELERON PHARMA I ... | Maniatis Tom | Director | Sell | S | 45.00 | 23,400 | 1,053,000 | 114,231 | 137.6 K to 114.2 K (-17.00 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | M | 5.88 | 4,000 | 23,520 | 8,500 | |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 37.44 | 1,100 | 41,184 | 27,890 | 29 K to 27.9 K (-3.79 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 36.10 | 1,000 | 36,100 | 28,990 | 30 K to 29 K (-3.33 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 34.87 | 1,900 | 66,253 | 29,990 | 31.9 K to 30 K (-5.96 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Buy | M | 5.88 | 4,000 | 23,520 | 31,890 | 27.9 K to 31.9 K (+14.34 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 5.08 | 2,500 | 12,700 | 6,250 | |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 1.80 | 2,969 | 5,344 | 11,094 | |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 0.92 | 2,031 | 1,869 | 0 | |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 37.41 | 700 | 26,187 | 52,656 | 53.4 K to 52.7 K (-1.31 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 36.16 | 600 | 21,696 | 53,356 | 54 K to 53.4 K (-1.11 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 34.89 | 1,200 | 41,868 | 53,956 | 55.2 K to 54 K (-2.18 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 5.08 | 2,500 | 12,700 | 55,156 | 52.7 K to 55.2 K (+4.75 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 37.27 | 1,300 | 48,451 | 52,656 | 54 K to 52.7 K (-2.41 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 36.24 | 1,100 | 39,864 | 53,956 | 55.1 K to 54 K (-2.00 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 34.97 | 2,600 | 90,922 | 55,056 | 57.7 K to 55.1 K (-4.51 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 1.80 | 2,969 | 5,344 | 57,656 | 54.7 K to 57.7 K (+5.43 %) |
Dec 02 2014 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 0.92 | 2,031 | 1,869 | 54,687 | 52.7 K to 54.7 K (+3.86 %) |